1 Consultant Psychiatrist, Blackpool and Fylde Hospital Group and Lancaster Moor Hospital
2 Professor of Psychological Medicine, University of Newcastle upon Tyne
3 Senior Lecturer in Applied Psychology, University of Newcastle upon Tyne
An investigation of 129 in-patient depressives treated with E.C.T. is presented. All were followed up to 3 months, and 108 to 6 months. Initially all were scored for the presence or absence of 35 features considered to discriminate between endogenous and neurotic depressions. Diagnoses were allocated before or early during treatment. Patients were rated at the termination of E.C.T. at 3 months and at 6 months, on a four-point scale. At 3 months, only 12 out of 63 neurotic depressives were found to have responded well to E.C.T., whereas out of 53 endogenous depressives had done so; the corresponding figures for 6 months were 8 out of 53 and 34 out of 44.
A factor analysis of the features produced three significant factors, a bipolar factor corresponding to the distinction between endogenous and neurotic depression, a general factor with high loadings for many features common to all the depressive cases studied and, probably, a paranoid psychotic factor. The bipolar factor closely resembles that extracted in a previous investigation (Kiloh and Garside, 1963) and supports the hypothesis that these are two distinct depressive populations. Among features with high positive loadings on the first factor, and thus corresponding to a diagnosis of endogenous depression, were adequate premorbid personality, absence of adequate psychogenic factors in relation to illness, a distinct quality to the depression, weight loss, pyknic body build, occurrence of previous depressive episode, early morning awakening, depressive psychomotor activity, nihilistic, somatic and paranoid delusions, and ideas of guilt. Among features with a negative loading corresponding to a diagnosis of neurotic depression were anxiety, aggravation of symptoms in the evening, self-pity, a tendency to blame others, and hysterical features.
By means of multiple regression analysis, three series of 18 weighted coefficients for the differential diagnosis between the two varieties of depression and for the prediction of E.C.T. response at 3 and 6 months were calculated. The multiple correlations between the summed features on the one hand and diagnosis and outcome at 3 and 6 months on the other were 0.91, 0.72 and 0.74 respectively. It was thought that E.C.T. response could be better predicted by the direct use of the weights for E.C.T. response than from the diagnostic weights alone. The weights based on the 18 features were complex, and therefore a further table was constructed giving simplified weights based on ten features of diagnosis and ten features for prediction of outcome of treatment with E.C.T. after 6 months.
Submitted on December 24, 1964
This article has been cited by other articles:
![]() |
V. NAVARRO, C. GASTO, F. LOMENA, X. TORRES, J. J. MATEOS, M. J. PORTELLA, G. MASANA, and T. MARCOS Prognostic value of frontal functional neuroimaging in late-onset severe major depression The British Journal of Psychiatry, April 1, 2004; 184(4): 306 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. PORTER, P. GALLAGHER, J. M. THOMPSON, and A. H. YOUNG Neurocognitive impairment in drug-free patients with major depressive disorder The British Journal of Psychiatry, March 1, 2003; 182(3): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Mulder, R. J. Porter, and P. R. Joyce The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol J Psychopharmacol, January 1, 2003; 17(1): 97 - 102. [Abstract] [PDF] |
||||
![]() |
J. D. Amsterdam Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression J Psychopharmacol, January 1, 1998; 12(4_suppl): S99 - S111. [Abstract] [PDF] |
||||
![]() |
R. T. Rubin, E. K. Heist, S. S. McGeoy, K. Hanada, and I. M Lesser Neuroendocrine Aspects of Primary Endogenous Depression: XI. Serum Melatonin Measures in Patients and Matched Control Subjects Arch Gen Psychiatry, July 1, 1992; 49(7): 558 - 567. [Abstract] [PDF] |
||||
![]() |
C. F. Duggan, A. S. Lee, and R. M. Murray Do Different Subtypes of Hospitalized Depressives Have Different Long-term Outcomes? Arch Gen Psychiatry, April 1, 1991; 48(4): 308 - 312. [Abstract] [PDF] |
||||
![]() |
P. R. Joyce and E. S. Paykel Predictors of Drug Response in Depression Arch Gen Psychiatry, January 1, 1989; 46(1): 89 - 99. [Abstract] [PDF] |
||||
![]() |
J. R. T. Davidson, E. L. Giller, S. Zisook, and J. E. Overall An Efficacy Study of Isocarboxazid and Placebo in Depression, and Its Relationship to Depressive Nosology Arch Gen Psychiatry, February 1, 1988; 45(2): 120 - 127. [Abstract] [PDF] |
||||
![]() |
D. Healy The comparative psychopathology of affective disorders in animals and humans J Psychopharmacol, January 1, 1987; 1(3): 193 - 210. [Abstract] [PDF] |
||||
![]() |
M. Zimmerman, W. Coryell, B. Pfohl, and D. Stangl The Validity of Four Definitions of Endogenous Depression: II. Clinical, Demographic, Familial, and Psychosocial Correlates Arch Gen Psychiatry, March 1, 1986; 43(3): 234 - 244. [Abstract] [PDF] |
||||
![]() |
N. C. Andreasen, W. Scheftner, T. Reich, R. M. A. Hirschfeld, J. Endicott, and M. B. Keller The Validation of the Concept of Endogenous Depression: A Family Study Approach Arch Gen Psychiatry, March 1, 1986; 43(3): 246 - 251. [Abstract] [PDF] |
||||
![]() |
R. C. Casper, D. E. Redmond Jr, M. M. Katz, C. B. Schaffer, J. M. Davis, and S. H. Koslow Somatic Symptoms in Primary Affective Disorder: Presence and Relationship to the Classification of Depression Arch Gen Psychiatry, November 1, 1985; 42(11): 1098 - 1104. [Abstract] [PDF] |
||||
![]() |
R. Kellner Functional Somatic Symptoms and Hypochondriasis: A Survey of Empirical Studies Arch Gen Psychiatry, August 1, 1985; 42(8): 821 - 833. [Abstract] [PDF] |
||||
![]() |
J. F. Leckman, K. A. Caruso, B. A. Prusoff, M. M. Weissman, K. R. Merikangas, and D. L. Pauls Appetite Disturbance and Excessive Guilt in Major Depression: Use of Family Study Data to Define Depressive Subtypes Arch Gen Psychiatry, September 1, 1984; 41(9): 839 - 844. [Abstract] [PDF] |
||||
![]() |
J. Davidson, C. Turnbull, R. Strickland, and M. Belyea Comparative Diagnostic Criteria for Melancholia and Endogenous Depression Arch Gen Psychiatry, May 1, 1984; 41(5): 506 - 511. [Abstract] [PDF] |
||||
![]() |
E. S. Paykel, P. R. Rowan, R. R. Parker, and A. V. Bhat Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression Arch Gen Psychiatry, September 1, 1982; 39(9): 1041 - 1049. [Abstract] [PDF] |
||||
![]() |
C. L. Ravaris, D. S. Robinppson, J. O. Ives, A. Nies, and D. Bartlett Phenelzine and Amitriptyline in the Treatment of Depression: A Comparison of Present and Past Studies Arch Gen Psychiatry, September 1, 1980; 37(9): 1075 - 1080. [Abstract] [PDF] |
||||
![]() |
J. R. T. Davidson, M. N. McLeod, C. D. Turnbull, H. L. White, and E. J. Feuer Platelet Monoamine Oxidase Activity and the Classification of Depression Arch Gen Psychiatry, July 1, 1980; 37(7): 771 - 773. [Abstract] [PDF] |
||||
![]() |
J. C. Nelson and D. S. Charney Primary Affective Disorder Criteria and the Endogenous-Reactive Distinction Arch Gen Psychiatry, July 1, 1980; 37(7): 787 - 793. [Abstract] [PDF] |
||||
![]() |
D. S. Robinson, A. Nies, C. L. Ravaris, J. O. Ives, and D. Bartlett Clinical Pharmacology of Phenelzine Arch Gen Psychiatry, May 1, 1978; 35(5): 629 - 635. [Abstract] [PDF] |
||||
![]() |
J. Davidson, M. McLeod, B. Law-Yone, and M. Linnoila A Comparison of Electroconvulsive Therapy and Combined Phenelzine-Amitriptyline in Refractory Depression Arch Gen Psychiatry, May 1, 1978; 35(5): 639 - 642. [Abstract] [PDF] |
||||
![]() |
P. E. Garfinkel, J. J. Warsh, H. C. Stancer, and D. D. Godse CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor Arch Gen Psychiatry, June 1, 1977; 34(6): 735 - 739. [Abstract] [PDF] |
||||
![]() |
E. Robins, K. A. Gentry, R. A. Munoz, and S. Marten A Contrast of the Three More Common Illnesses With the Ten Less Common in a Study and 18-Month Follow-up of 314 Psychiatric Emergency Room Patients: II. Characteristics of Patients With the Three More Common Illnesses Arch Gen Psychiatry, March 1, 1977; 34(3): 269 - 281. [Abstract] [PDF] |
||||
![]() |
D. E. Sternberg and M. E. Jarvik Memory Functions in Depression: Improvement With Antidepressant Medication Arch Gen Psychiatry, February 1, 1976; 33(2): 219 - 224. [Abstract] [PDF] |
||||
![]() |
W. W. K. Zung From Art to Science: The Diagnosis and Treatment of Depression Arch Gen Psychiatry, September 1, 1973; 29(3): 328 - 337. [Abstract] [PDF] |
||||
![]() |
D. S. Robinson, A. Nies, C. L. Ravaris, and K. R. Lamborn The Monoamine Oxidase Inhibitor, Phenelzine, in the Treatment of Depressive-Anxiety States: A Controlled Clinical Trial Arch Gen Psychiatry, September 1, 1973; 29(3): 407 - 413. [Abstract] [PDF] |
||||
![]() |
M. D. Blumenthal Heterogeneity and Research on Depressive Disorders Arch Gen Psychiatry, June 1, 1971; 24(6): 524 - 531. [Abstract] [PDF] |
||||
![]() |
A. Raskin, J. G Schulterbrandt, N. Reatig, C. Chase, and J. J McKeon Differential Response to Chlorpromazine, Imipramine, and Placebo: A Study of Subgroups of Hospitalized Depressed Patients Arch Gen Psychiatry, August 1, 1970; 23(2): 164 - 173. [Abstract] [PDF] |
||||
![]() |
E. S. Paykel, G. L. Klerman, and B. A. Prusoff Treatment Setting and Clinical Depression Arch Gen Psychiatry, January 1, 1970; 22(1): 11 - 21. [Abstract] [PDF] |
||||